https://www.gireconnect.org/2024-friday-webcasts/combining-therapies-for-ibd%3A-rationale-and-practical-aspects 2024-09-19 https://www.gireconnect.org/2024-friday-webcasts/playing-jaks%3A-right-patient%2C-right-time%2C-right-dose 2024-09-19 https://www.gireconnect.org/2024-friday-webcasts/selecting-first-line-advanced-therapy-in-crohn's-disease 2024-09-19 https://www.gireconnect.org/2024-friday-webcasts/how-%22i%22-select-first-line-advanced-therapies-for-moderate-severe-ulcerative-colitis 2024-09-19 https://www.gireconnect.org/2024-friday-webcasts/will-someone-define-what-is-moderate-to-severe-disease%3F 2024-09-19 https://www.gireconnect.org/2024-friday-webcasts/current-%26-future-utility-of-intestinal-ultrasound-for-disease-monitoring 2024-09-19 https://www.gireconnect.org/2024-friday-webcasts/will-ai-change-our-approach-to-mucosal-healing%3F 2024-09-19 https://www.gireconnect.org/2024-friday-webcasts/tracking-disease-activity-and-treatment-response-in-ibd%3A-biomarkers-and-wearables 2024-09-19